Discover Our Group:

Berlin-Chemie has been developing, manufacturing and distributing pharmaceutical products for over 130 years and has been a wholly owned subsidiary of the Menarini Group, the leading Italian pharmaceutical company, since 1992. 

Responsibility is a top priority at Berlin-Chemie. We not only make an important contribution to healthcare, but also put our values into practice through various social initiatives.

Discover More about Global Responsibility

From school kits to free meals and medicines, to caring for the environment around the world. In Menarini, being responsible means translating our values into concrete actions that are good for others and good for the planet

Berlin-Chemie – a strong partner. Our many years of experience and the success of joint projects make us the partner of choice. 

Discover More about Global Partnering

Menarini has in-depth know-how in many important therapeutic areas, thanks to many years of excellent market introduction, marketing and sales capabilities as well as expertise in regulatory aspects and market access. Collaboration is the key to great success, and at Menarini, partnership is part of the DNA.

Our holistic and professional health management offers doctors individual counselling, training or workshops, events and lectures on many topics, depending on their needs.

Our Medical Hub acts as a central point of contact for doctors and healthcare professionals. Here you will find all the information about our medications, additional service and training opportunities.

Welcome to the News & More section. Here you will find general information in the form of press releases, news and the latest graphical material. 

Menarini Blog

Follow Us

We employ professionals with a wide variety of career backgrounds and are employers who care about their staff. Together, we stand for innovation and reliability.

Our Job Portal

Find out about our current vacancies at Berlin-Chemie directly on our career portal.

Menarini Group News

2014 - 06 - 20

Menarini: one of top ten most "patient friendly" companies

An independent Corporate Reputation Survey of Pharma Companies, including 800 patient groups in 43 countries worldwide, ranked Menarini amongst the world’s top ten Pharmaceutical companies closest to patients’ needs.


Being close to one’s patients is a quality that cannot be measured in terms of turnover or size and even a company like Menarini can come close or even exceed the level of Big Pharma, just like David and Goliath. Menarini, 37th out of 19,042 companies in the worldwide ranking in terms of turnover, was awarded 4th place for its patient-centric strategies and for acting with integrity and 6th place for the high quality information it provides to patients. This is the outcome of an independent study conducted on 800 patient groups by PatientView, a UK-based research company which works closely with patient groups in order to give them voice, and which resulted in a ranking of the world’s most ‘patient friendly’ pharmaceutical companies. According to the outcome of the 2013 Corporate Reputation survey, which included patient groups from 43 countries worldwide, Menarini ranked high amongst the world’s “top ten” Pharma companies regarded as closest to patients’ needs. It was also considered one of the three companies who stood out as “Rising Stars”, with a significant upward shift in the overall, worldwide ranking compared to last year’s ranking. In the global ranking Menarini jumped 11 places from 19th to 8th position, overtaking some of the world’s most renowned Pharma companies such as ViiV, Gilead, AbbVie, Pfizer, Janssen, Roche, and Eli Lilly, surprisingly leaving some of the larger Big Pharma multinationals behind them.   The six performance indicators PatientView adopted for the survey were patient centricity, quality of information provided, record on patient safety, usefulness of products to patients, record of transparency towards patients and consumers, and acting with integrity.   Menarini ranked high in all the categories thanks to a number of patient-oriented initiatives, such as a toll free number made voluntarily available to patients through which they may consult physicians and seek assistance in relation to a number of different medical conditions, the opportunity to pose anonymous questions to experts and consultants through the company’s website, and the introduction of “patient cards”  which accompany the patient leaflets and provide further information on both the therapy and medicines which might interact with the product in question. “We are proud of the results attained by Menarini as far as our reputation with patients is concerned as this is tangible recognition of our mission to purvey the highest possible quality drugs and services” – commented the Chairman of The Menarini Group, Lucia Aleotti – “patients are at the centre of what we do and must be increasingly informed, knowledgeable, and responsible.”